HAYWARD, Calif., March 22, 2023 /PRNewswire/ — Avirmax CMC Inc. (ACI), a cGMP-licensed CDMO, is announcing the implementation of its newly-developed Sf rhabdovirus-free cell lines (under the generic trademark of Sf-RVF™) developed for producing recombinant adeno-associated viral vectors…